Product
IB1001
Aliases
N-Acetyl-L-Leucine
3 clinical trials
7 indications
Indication
GM2 GangliosidosisIndication
Tay-Sachs DiseaseIndication
Sandhoff diseaseIndication
Ataxia TelangiectasiaIndication
Barlow's diseaseIndication
Niemann-Pick DiseaseIndication
Type CClinical trial
Effects of N-Acetyl-L-Leucine on GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease): A Multinational, Multicenter, Open-label, Rater-blinded Phase II StudyStatus: Completed, Estimated PCD: 2023-01-09
Clinical trial
Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T): A Multinational, Multicenter, Open-label, Rater-blinded Phase II StudyStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Effects of N-Acetyl-L-Leucine on Niemann Pick Type C Disease: A Multinational, Multicenter, Open-label, Rater-blinded Phase II Study.Status: Completed, Estimated PCD: 2022-11-07